Furthermore, the ratio of SA-β-gal-positive cells (Figure 4E, 4F) and the distribution of F-actin (Figure 4G) in BMMSCs from SLE patients was effectively reversed after treatment with TLR4-siRNA. The gene discussed is TLR4; the disease is systemic lupus erythematosus.